Skip to content

歐嘉隆台灣 logo

Main menu
    • 我們的故事
    • 了解我們名字的由來
    • 願景、使命和價值觀
    • 多元性、公平性和包容性
    • 環境保護、社會責任和企業治理
    • 我們的重點領域
    • 產品列表
    • Nasonex 內舒拿小藍瓶
  • 新聞
  • 歐嘉隆台灣
  • 加入我們

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

多元性、公平性和包容性

我們公司的核心

我們的歸屬感

為了成為我們希望在世界上看到的差異的一部分,我們為多元性發出強有力的聲音。多元性在我們所做的一切中都很重要──從我們聘僱的團隊到接收到我們藥物的民眾。

我們相信,當我們鼓勵的獨特觀點和背景大放異彩時,我們就能履行我們的使命,改善全球女性的醫療保健。

職涯

個人和公司的蓬勃發展

我們創造一種文化,讓我們的員工感到自己有歸屬感。每位歐嘉隆員工都對我們是誰、我們做了什麼以及我們公司的行動產生影響。

準備好加入我們的團隊了嗎?

職涯

員工資源小組

我們的員工資源小組 (ERG) 是由員工領導的團隊,旨在促進多元化、包容性的工作場所。每個群體都因共同的興趣或共同的特色而結合在一起,無論是性別、種族、宗教信仰、生活方式還是興趣。

了解我們的文化
徹底的性別平等

我們由一支極其多元化的團隊來領導我們的公司,女性員工的比例超過了同業平均。我們董事會的女性人數超過任何標準普爾 500 指數的醫療保健公司,而且我們的執行領導團隊有一半是女性。

認識我們的領導團隊
與不同的夥伴合作

我們積極在供應鏈中與小型、少數群體、女性、退伍軍人、女同性戀、男同性戀、雙性戀和跨性別 (LGBT)以及身心障礙人士所擁有的企業組織建立合作。

更多關於我們的供應商

TW-NON-110192 Oct/2024

歐嘉隆台灣 logo
  • Cookie 政策
  • 隱私權政策
  • 使用條款
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept